MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Articles tagged "Cognitive dysfunction"

  • 2019 International Congress

    The interplay between cholinergic activity, attention, and turning in Parkinson’s disease

    R. Morris, D. Martini, G. Mcbarron, M. Mancini, F. Horak (Portland, OR, USA)

    Objective: Explore how cholinergic activity (measured by short latency afferent inhibition [SAI]) and attention relate to quality of turning performance over a week of daily…
  • 2019 International Congress

    Relationship between cognitive performance and mobility in patients with Parkinson´s disease: A cross-sectional study

    N. Sousa, R. Macedo, S. Brucki (Salvador, Brazil)

    Objective: To investigate the relationships between cognitive ability (global and single domain-executive functions) and gait performance (balance, gait speed and mobility) in patients with Parkinson's…
  • 2019 International Congress

    Health associated quality of life (HAQL) and humor/cognitive complaints predict mortality in Parkinson’s disease (PD)

    P. Bugalho, R. Barbosa, F. Ladeira, J. Marto, C. Borbinha, L. Conceição, M. Saraiva, M. Salavisa, B. Meira, M. Fernandes (Lisbon, Portugal)

    Objective: To assess the value of motor (MS), non-motor symptoms (NMS), HAQL and activities of daily living (ADL) for predicting mortality in PD. Background: Parkinson’s…
  • 2019 International Congress

    Association of MRI-derived estimated brain age and cognitive ability in Parkinson’s disease

    K-L. Horne, R. Shoorangiz, L. Livingston, S. Grenfell, M. Almuqbel, B. Young, M. Pascoe, M. Livingstone, M. Macaskill, D. Myall, T. Pitcher, T. Anderson, J. Dalrymple-Alford, T. Melzer (Chrsitchurch, New Zealand)

    Objective: To characterise MRI-derived structural age-related brain health in Parkinson’s disease (PD) patients as a function of cognitive ability. Background: Normal ageing produces a stereotypical…
  • 2019 International Congress

    Comorbidities and medications in Huntington’s disease, Parkinson’s disease and the general population in a US claims database

    L. Ishihara, E. Wild, D. Oliveri (Welwyn Garden City, United Kingdom)

    Objective: This study characterises the comorbidities and symptoms, and treatment patterns of patients with Huntington’s disease (HD) vs patients with Parkinson’s disease (PD) vs the…
  • 2019 International Congress

    Are Cognitive Changes in Hereditary Spastic Paraplegias Restricted to Complicated Forms?

    L. Jacinto-Scudeiro, G. Machado, A. Ayres, D. Burguêz, M. Polese-Bonatto, C. González-Salazar, M. Siebert, M. França Jr, M. Olchik, J. Saute (Porto Alegre, Brazil)

    Objective: We aimed to characterize cognitive functions of patients with pure and complicated HSP, and to determine the frequency of abnormal cognitive performances in the…
  • 2019 International Congress

    Metabolic syndrome and insulin resistance in Parkinson’s disease: could they affect motor or cognitive symptoms?

    M. Hussein, A. Khamis, R. Soliman, S. Ali (Beni Suef, Egypt)

    Objective: The objective of this work was to detect the markers of metabolic syndrome and insulin resistance in patients with PD and to study their…
  • 2019 International Congress

    A Neuroscientific approach for MCI Characterization using a Motor and Cognitive Dual-Task

    G. Mancioppi, F. Fiorini, M. Timpano Sportiello, E. Rovini, F. Cavallo (Pontedera, Italy)

    Objective: To investigate the relationship between cognition and motion skills, through an innovative technological tool able to quantify gait parameters, while providing for a Motor…
  • 2019 International Congress

    Cognitive impairment profile of patients with Essential Tremor and Parkinson’s Disease

    A. Abundes-Corona, A. Cervantes-Arriaga, R. Zerón-Martínez, R. Solís-Vivanco, O. Cárdenas-Saenz, M. Rodríguez-Violante (Mexico City, Mexico)

    Objective: To identify if the Montreal Cognitive Assessment (MoCA) is a sensible tool to differentiate cognitive impairment profiles between patients with Essential Tremor (ET) and…
  • 2019 International Congress

    Relating web-based-visuo-perception to cognition and genetic variability in Parkinson’s disease: interim report

    A. Costantini, M. Tan, M. Lo, L. Leyland, H. Morris, R. Weil (London, United Kingdom)

    Objective: To relate visuo-perceptual performance with cognitive and genetic measures in Parkinson’s disease. Background: Dementia is a common occurrence in Parkinson’s disease (PD), affecting up…
  • « Previous Page
  • 1
  • …
  • 67
  • 68
  • 69
  • 70
  • 71
  • …
  • 128
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley